Schedule 13G ownership disclosure

Beta Bionics Inc

Common Stock · CUSIP: 08659B102

Event date: 2025-09-30

Filing-level shares
2,216,185
Percent of class
5.09%
  • The Vanguard Group

    Shares: 2,216,185 · Class: 5.09%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000102909-25-000056
Form type
SCHEDULE 13G
Filer
Beta Bionics, Inc.
CIK
CIK 1674632
Filed
Oct 30, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub